Respiratory Syncytial Virus (RSV)

  • The US Food and Drug Administration (FDA) granted approval for the first vaccine designed to safeguard newborns from Respiratory Syncytial Virus (RSV).
  • Respiratory Syncytial Virus (RSV) primarily affects the lungs and respiratory tract, posing a significant risk to children and the elderly.
  • Pfizer's newly approved vaccine is intended to safeguard newborns by administering it to mothers during the latter stages of pregnancy.
  • This approach ensures protection for infants during their critical first six months of ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content

Already a Member? Login here

Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material since 2018 of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Be an Annual Subscriber

News Snippets